Zydus Cadila signs pact with IMTECH

July 05, 2018 | Thursday | News

The agreement has been signed to identify new drug candidates for treatment of drug resistant infections.

Image credit- quora.com

Image credit- quora.com

Zydus Cadila has inked an agreement with Council of Scientific and Industrial Research (CSIR) - Institute of Microbial Technology (IMTECH) to identify new drug candidates for treatment of drug resistant infections.

The collaborative research agreement will see scientists from both organisations working together on microbiology and genomics to identify new lead candidate as novel anti-tuberculosis compound.

For this project, scientists at IMTECH will utilise their expertise and scientific knowledge in microbiology while Zydus Cadila will provide expertise in medicinal chemistry and pharmaceutical drug development to develop new drug combinations against drug-resistant pathogens which causes severe diseases in India and across the world.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy